Grant

PNA5: A Novel Mas Receptor Agonist for Treatment of Cognitive Impairment in Patients at Risk for Vascular Dementia and Alzheimer's Disease Related Dementia: An FDA Required Toxicology

Sponsored by National Institute on Aging

Active

$3.9M Funding

4 People

External

Related Topics

cognitive impairment, vascular dementia, alzheimer's disease, mas receptor agonist, toxicology

People

Bruce Coull
Co-Investigator (COI)
Neurology﹒Vice Dean
Todd Vanderah
Multiple Principal Investigator (MPI)
Pharmacology﹒Department Head
Roberta Brinton
Key Personnel (KP)
Pharmacology﹒Director
Meredith Hay
Principal Investigator (PI)
Physiology﹒Professor